A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07116616 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions

DRUG: mRNA-2808

Sponsor

ModernaTX, Inc.